Hyperfine, Inc. (HYPR) vs LENSAR, Inc. (LNSR)
Hyperfine, Inc. and LENSAR, Inc. are both Medical Devices companies. Hyperfine, Inc. and LENSAR, Inc. are of similar size ($86.9M and $84.4M). Hyperfine, Inc. has negative trailing earnings, so its P/E is not meaningful; LENSAR, Inc. trades at 2.4×. Hyperfine, Inc. grew revenue faster over the last twelve months: 53.2% against 3.26%. LENSAR, Inc. has the higher net margin (57.6% vs −210.8%) and the higher return on invested capital (−379.0% vs −401.8%). Across the 18 metrics below, LENSAR, Inc. leads on 11 and Hyperfine, Inc. on 7.
Valuation
Profitability
| Metric | HYPR | LNSR | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.41% | 48.34% | 56.01% |
| Operating margin | (203.27%) | (13.48%) | (15.03%) |
| Net margin | (210.75%) | 57.57% | (20.40%) |
| Free cash flow margin | (166.48%) | (12.29%) | (7.24%) |
| Return on equity | (96.97%) | (851.75%) | (15.32%) |
| Return on assets | (64.40%) | 49.58% | (19.72%) |
| Return on invested capital | (401.79%) | (379.01%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack